Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K222034
    Date Cleared
    2022-09-07

    (58 days)

    Product Code
    Regulation Number
    878.4850
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    RightLance Blood Lancing System

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The RightLance Blood Lancing System is intended for the hygienic collection of capillary blood for testing purposes from the side of a fingertip and from alternative sites, such as the palm, the upper arm, and the forearm.

    The sterile, single-use lancets are to be used with the reusable lancing device that is to be cleaned and disinfected between each use, and then the lancets are to be disposed of.

    This system is for use only on a single patient in a home setting.

    This system is not suitable for use by healthcare professionals with multiple patients in a healthcare setting.

    Device Description

    The proposed device, RightLance Blood Lancing System is intended for the hygienic collection of capillary blood for testing purposes from the side of a fingertip and from alternative sites, such as the palm, the upper arm, and the forearm.

    The sterile, single-use lancets are to be used with the reusable lancing device that is to be cleaned and disinfected between each use, and then the lancets are to be disposed of.

    This system is for use only on a single patient in a home setting.

    This system is not suitable for use by healthcare professionals with multiple patients in a healthcare setting.

    The RightLance Blood Lancing System is made up of Lancing Device and Disposable Lancet.

    The Model of Lancing Device: RC-AD-III; RC-AD-IIIT; RC-AD-VIU; RC-AD-VIX; RC-AD-VIXT; RC-AD-VII; RC-AD-XI; RC-AD-XII; RC-AD-XIV; Sinodraw; RC-LD-16; RC-LD-17; RC-LD-18; RC-LD-19

    The Model of Disposable Lancet: I Size: 21G, 23G, 25G, 26G, 27G, 28G, 30G, 31G, 32G, 33G

    AI/ML Overview

    This is a 510(k) premarket notification for a medical device called the RightLance Blood Lancing System. The document focuses on establishing substantial equivalence to a predicate device, the Accu-Chek Softclix Blood Lancing System, rather than providing a detailed study that proves the device meets specific acceptance criteria as one might find for an AI/ML powered device.

    Therefore, many of the requested elements for AI/ML device studies (like effect size for MRMC studies, training set details, or complex ground truth establishment) are not applicable to this type of submission.

    Here's an analysis based on the provided text, focusing on what is relevant for a non-AI medical device submission:

    Acceptance Criteria and Device Performance

    There isn't a table of quantitative performance acceptance criteria in the typical sense of measuring algorithm accuracy (e.g., sensitivity, specificity). Instead, the "acceptance criteria" are implied by the comparison to the predicate device and compliance with recognized international standards and internal design specifications. The device is accepted if it performs "as well as or better than" the predicate device and meets its own design specifications.

    The comparison table provided (page 4) details the technological characteristics, highlighting similarities and differences with the predicate.

    Table of Acceptance Criteria (Implied by Predicate Comparison and Standards) and Reported Device Performance

    Acceptance Criterion (Implied)Reported Device Performance (Summary of Non-Clinical Testing)
    Indications for Use (IFU)The RightLance Blood Lancing System has the same IFU as the predicate device (Accu-Chek Softclix Blood Lancing System) for hygienic collection of capillary blood from fingertip and alternative sites, single-patient home use, and not for healthcare professionals with multiple patients.
    Technological Characteristics (Design, Mechanism, Operation, Energy, Features, Form, Fit, Function)"The RightLance Blood Lancing System and predicate device share the same technological characteristics including their design, mechanical mechanism, principle of operation, energy source and usage, features, form, fit, and function." (Page 5) Detailed comparison provided in table on page 4 (Needle size, depth adjustment, mechanical loading, load/firing, anatomical sites, sharps injury prevention).
    BiocompatibilityComplies with ISO 10993-5 (cytotoxicity), ISO 10993-10 (irritation and skin sensitization), ISO 10993-11 (systemic toxicity), ISO 10993-4 (interactions with blood).
    SterilizationComplies with ISO 11137-2 for establishing sterilization dose (gamma irradiation).
    PyrogenicityComplies with USP34 Rabbit Pyrogen Test.
    Performance (Functional Safety & Efficacy based on physical attributes)Bench tests conducted for: Basic Size, Puncture Depth, Lancing Device Cap Removal, Lancing Device Firing Force, Drop, Drawing Force, The tightness of lancing device. These tests "demonstrated that the proposed device complies with its design specification." (Page 7) Specific quantitative results are not provided in this summary.
    Shelf Life (Aging)Validation performed.

    Study Details (as applicable)

    1. Sample size used for the test set and the data provenance:

      • No "test set" in the context of an AI/ML algorithm evaluation.
      • For the non-clinical bench testing, the sample sizes are not specified in the provided summary.
      • Data provenance: Not applicable for this type of device where laboratory bench testing is the primary evidence.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • Not applicable. There is no "ground truth" establishment by experts for this type of mechanical lancing device. The performance is assessed against engineering specifications and international standards.
    3. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

      • Not applicable. No expert adjudication process is described or relevant for this device.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No. This is not an AI/ML powered device, so MRMC studies are not relevant.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

      • Not applicable. This is a manual mechanical device, not an algorithm. The non-clinical tests assess the device's physical and functional performance directly.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • For this device, "ground truth" would be defined by engineering specifications, international standards (e.g., ISO, USP), and the performance characteristics of the predicate device. For example, a "puncture depth" test would have an expected range based on design, and the device's output would be measured against that.
    7. The sample size for the training set:

      • Not applicable. This is not an AI/ML device, so there is no training set.
    8. How the ground truth for the training set was established:

      • Not applicable. No training set.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1